← Back
$WGS All transactions

GeneDx Holdings Corp.

M 10b5-1 Plan

$ Value

$0

Shares

1,246

Price

$0

Filed

Oct 1

Insider

Name

Feeley Kevin

Title

CHIEF FINANCIAL OFFICER

CIK

0001944119

Roles

Officer

Transaction Details

Transaction Date

2025-09-30

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,982

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.1354 to $107.01, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.22 to $108.20, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.23 to $109.1754, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.3225 to $110.25, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive. | Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 3,392 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 124,633 shares of Class A common stock and options to purchase up to an aggregate of 25,906 shares of Class A common stock, which RSUs and options vest according to their respective terms. | The award vested or vests as to 6.25% of the total award quarterly over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Filing Info

Accession No.

0001944119-25-000012

Form Type

4

Issuer CIK

0001818331

Feeley Kevin's History

Date Ticker Type Value
2026-03-26 WGS M $0
2026-03-26 WGS $152K
2026-03-26 WGS $60K
2026-03-26 WGS $159K
2026-03-26 WGS $64K
2026-03-26 WGS $121K
2026-03-26 WGS M $0
2026-01-29 WGS M $0
2026-01-29 WGS $30K
2026-01-29 WGS $184

Other Insiders at WGS (90d)

Insider Bought Sold Last
Stueland Katherine
CHIEF EXECUTIVE OFFICER
$3.1M 2026-03-26
Feeley Kevin
CHIEF FINANCIAL OFFICER
$587K 2026-03-26
Dechairo Bryan
Chief Operating Officer
$851K 2026-02-04